Ditto Biosciences
Evolutionary intelligence for autoimmune disease
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction Ditto Biosciences is a Y Combinator company (Winter 2026). YC-listed status: Active.
- Website
- dittobio.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Ditto Bio — AI drug discovery platform that identifies parasite-derived proteins to develop next-generation autoimmune therapies. · Other
Links
- Y Combinator profileycombinator